Boler Biotech Consulting is a Boston based biotechnology investing and consulting firm focused on early stage, private, and public Life Science companies.

 

We provide strategic research and analysis for investors and clients with early-stage biotechnology companies. This includes scientific assessment, due diligence, and analysis of market potential of new technologies and therapies.

 

We pride ourselves on identifying and partnering with startup companies and investors who successfully commercialize technologies most likely to improve the lives of patients and yield robust returns for investors.